Distinct signature type I interferon responses are determined by the infecting virus and the target cell

Antiviral Therapy

Volumn 13, Issue 3, 2008, Pages 409-422

  Baig, Ehtesham ^a   Fish, Eleanor N ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; ALPHA4 INTERFERON; ALPHA5 INTERFERON; INTERFERON; PROTEIN DERIVATIVE; SINGLE STRANDED RNA; ALPHA INTERFERON; ALPHA INTERFERON 4; ALPHA INTERFERON 5; INTERFERON-ALPHA 2; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGY; C57BL 6 MOUSE; CELL TYPE; CONTROLLED STUDY; COXSACKIE VIRUS B3; FEMALE; FIBROBLAST; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; KINETICS; MOUSE; MOUSE STRAIN; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; RNA VIRUS; SENDAI VIRUS; TARGET CELL; VIRUS INFECTION; A J MOUSE; ANIMAL; C57BL MOUSE; CELL LINE; COMPARATIVE STUDY; ENTEROVIRUS; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PATHOGENICITY; POLYMERASE CHAIN REACTION; PROMOTER REGION; SPECIES DIFFERENCE; VIROLOGY;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; ENTEROVIRUS B, HUMAN; FEMALE; FIBROBLASTS; INTERFERON-ALPHA; KINETICS; MICE; MICE, INBRED A; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MURINE HEPATITIS VIRUS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); SENDAI VIRUS; SPECIES SPECIFICITY;

EID: 47249129985     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Chen J, Baig E, Fish EN. Diversity and relatedness among the type I interferons. J Interferon Cytokine Res 2004; 24:687-698.
2. Uze G, Lutfalla G, Gresser I. Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 1990; 60:225-234.
3. Novick D, Cohen B, Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 1994; 77:391-400.
4. Lutfalla G, Holland SJ, Cinato E, et al. Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J 1995; 14:5100-5108.
5. Brierley MM, Fish EN. Stats: multifaceted regulators of transcription. J Interferon Cytokine Res 2005; 25:733-744.
6. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5:375-386.
7. Akira S. TLR signaling. Curr Top Microbiol Immunol 2006; 311:1-16.
8. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007; 7:179-190.
9. Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101-105.
10. Cao W, Liu YJ. Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol 2007; 19:24-30.
11. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23:275-306.
12. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303:1529-1531.
13. Hochrein H, Schlatter B, O'Keeffe M, et al. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci U S A 2004; 101:11416-11421.
14. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413:732-738.
15. Matsumoto M, Funami K, Tanabe M, et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003; 171:3154-3162.
16. Honda K, Yanai H, Negishi H, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434:772-777.
17. Prakash A, Smith E, Lee CK, Levy DE. Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J Biol Chem 2005; 280:18651-18657.
18. Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box helicases RIGT, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005; 175:2851-2858.
19. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005; 6:981-988.
20. Khabar KSA, Young HA. Post-transcriptional control of the interferon system. Biochimie 2007; 89:761-769.
21. Paun A, Pitha PM. The IRF family, revisited. Biochimie 2007; 89:744-753.
22. Mesplede T, Navarro S, Genin P, et al. Positive and negative control of virus-induced interferon - A gene expression. Autoimmunity 2003; 36:447-455.
23. Civas A, Genin P, Morin P, Lin R, Hiscott J. Promoter organization of the interferon - A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon. J Biol Chem, 2006; 281:4856-4866.
24. Paz S, Sun Q, Nakhaei P, et al. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway. Cell Mol Biol 2006; 52:17-28.
25. Lopez S, Island ML, Drouin J, et al. Repression of virus-induced interferon A promoters by homeodomain transcription factor Ptx1. Mol Cell Biol 2000; 20:7527-7540.
26. Lamonerie T, Tremblay JJ, Lanctot C, et al. Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene. Genes Dev 1996; 10:1284-1295.
27. Hannigan GE, Gewert DR, Fish EN, Read SE, Williams BR. Differential binding of human interferon-alpha subtypes to receptors on lymphoblastoid cells. Biochem Biophys Res Commun 1983; 110:537-544.
28. Fish EN, Banerjee K, Stebbing N. Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells. Biochem Biophys Res Commun 1983; 112:537-546.
29. Faisca P, Desmecht D. Sendai virus, the mouse parainfluenza type 1: a longstanding pathogen that remains up-to-date. Res Vet Sci 2007; 82:115-125.
30. Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 2005; 69:635-664.
31. De Albuquerque N, Baig E, Ma X, et al. Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J Virol 2006; 80:10382-10394.
32. Oganesyan G, Saha SK, Guo B, et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006; 439:208-211.
33. Deonarain R, Alcami A, Alexiou M, et al. Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J Virol 2000; 74:3404-3409.
34. Kim KS, Hufnagel G, Chapman NM, Tracy S. The group B coxsackieviruses and myocarditis. Rev Med Virol 2001; 11:355-368.
35. Archard LC, Khan MA, Soteriou BA, et al Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 1998; 29:578-584.
36. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 1994; 74:182-188.
37. Opavsky MA, Martino T, Rabinovitch M, et al. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 2002; 109:1561-1569.
38. Opavsky MA, Penninger J, Aitken K, et al. Susceptibility to myocarditis is dependent on the response of alpha beta T lymphocytes to coxsackieviral infection. Circ Res 1999; 85:551-558.
39. Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN. Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 2004; 110:3540-3543.
40. Pichlmair A, Reis e Sousa C. Innate recognition of viruses. Immunity 2007; 27:370-383.
41. Agalioti T, Lomvardas S, Parekh B, et al. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 2000; 103:667-678.
42. Barnes BJ, Field AE, Pitha-Rowe PM. Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J Biol Chem 2003; 278:16630-16641.
43. Melchjorsen J, Jensen SB, Malmgaard L, et al. Activation of innate defense against a paramyxovirus is mediated by RIG-I amd TLR8 in a cell-type-specific manner. J Virol 2005; 79:12944-12951.
44. Komatsu T, Takeuchi K, Yokoo J, Gotch B. C and V proteins of Sendai virus target signalling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production. Virology 2004; 325:137-148.
45. Spiegel M, Pichlmair A, Martinex-Sobrido L, et al. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 2005; 79:2070-2086.
46. Fung MC, Sia SF, Leung KN, Mak NK. Detection of differential expression of mouse interferon-alpha subtypes by polymerase chain reaction using specific primers. J Immunol Methods 2004; 103:177-186.
47. Fitzgerald-Bocarshy P, Feng D. The role of type I interferon production by dendritic cells in the host defense. Biochemie 2007; 89;843-855.
48. Delhaye S, Paul S, Blakqori G, et al. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A 2006; 103:7835-7840.
49. Barchet W, Cella M, Odermatt B, et al. Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med 2002; 195:507-516.
50. Malmgaard L. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 2004; 24:439-454.
51. Osterkund P, Veckman V, Siren J, et al. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 2005; 79:9608-9617.
52. Wenzel J, Uerlich M, Haller O, Bieber T, Tueting T. Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod. J Cutan Pathol 2005; 32:257-262.
53. Pope MS, Cheung SW, Mossmann T, Leibowitz JL, Gorczynski RM, Levy GA. Resistance of naive mice to murine hepatitis virus strain 3 (MHV-3) requires development of THl, but not TH2 response, whereas pre-existing antibody protects against primary infection. J Immunol 1996; 156:3342-3349.
54. Slifka MK, Whitton JL. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat Immunol 2001; 2:711-717.
55. Haller O, Kochs G, Weber F. Interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006; 344:119-130.
56. Haller O, Weber F. Pathogenic viruses: smart manipulators of the interferon system. Curr Top Microbiol Immunol 2007; 316:315-334.
57. Symons JA, Alcami A, Smith GL. Vaccnia virus encodes a soluble type I inteferon receptor of novel structure and broad species specificity. Cell 1995; 81:551-560.